We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 75,628

National Health Data System is Launched
  • Squire Patton Boggs
  • France
  • May 24 2017

The National Health Data System (the SNDS, i.e. The Systme National des Donnes de Sant) was launched on 10 April 2017. The SNDS is an integrated


Florida Board of Medicine to Hold Another Hearing on Telemedicine and Medical Marijuana Rules
  • Foley & Lardner LLP
  • USA
  • May 24 2017

On August 4, 2017, the Florida Board of Medicine will hold a third public hearing to discuss its proposed amendment to Florida’s telemedicine


China to Coordinate the Linkage between Patent and Drug Registration
  • AFD China Intellectual Property Law Office
  • China
  • May 24 2017

The Food and Drug Administration of China (CFDA) recently published the draft of Regulations on Promoting Innovation of Drug and Medical Devices and


Filing Patents Does Not Create Jurisdiction Outside of the E.D. Virginia
  • Holland & Knight LLP
  • USA
  • May 24 2017

Judge Pallmeyer granted declaratory judgment defendants’ Fed. R. Civ. P. 12(b) motion to dismiss for lack of personal jurisdiction in this ANDA


Reading the Signs: Is a Marijuana Crackdown in Our Future?
  • Seyfarth Shaw LLP
  • USA
  • May 24 2017

We recently reported on the inclusion of the Rohrabacher-Farr Amendment in the current Congressional budget deal. The controversy over whether the


Health and Human Services Budget
  • Mintz Levin Cohn Ferris Glovsky and Popeo PC
  • USA
  • May 24 2017

The White House released its 2018 budget proposal this morning, outlining its priorities for the upcoming fiscal year. In health care, the President


The Commission steps into the excessive pricing arena
  • Bristows LLP
  • European Union
  • May 23 2017

An announcement by the European Commission last week resolve an open question about its view on the recent spate of pharma sector excessive pricing


CAFC Finds ANDA Infringement Despite Differences Between FDA Labeling And Claim Language
  • Foley & Lardner LLP
  • USA
  • May 23 2017

In a non-precedential decision issued in Braintree Labs., Inc. v. Breckenridge Pharmaceutical, Inc., the Federal Circuit reversed the district


Excessive pricing in pharmaceutical products attracts the European Commission’s attention
  • Hogan Lovells
  • European Union
  • May 23 2017

In recent years competition authorities in a number of EU Member States have stepped up in their pursuit against companies active in the Life


Pharmacy Law Trends Q&A: Opioids, Specialty Drugs Among Top Issues for Retail Pharmacies
  • Quarles & Brady LLP
  • USA
  • May 23 2017

The opioid crisis in the United States continues to worsen, with the Centers for Disease Control reporting more than 33,000 human deaths by overdose